New Key Statistics Module, Z-Score and F-Score
NAS:AUPH Key Ratios
| Market Cap $ M | 1,267.14 |
| Enterprise Value $ M | 986.20 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 15.44 |
| Price/Book | 3.27 |
| Price/Sales | 5.82 |
| Price/Free Cash Flow | 45.39 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 220.00 |
| EPS (TTM) $ | -0.14 |
| Beneish M-Score | -2.88 |
| 10-y EBITDA Growth Rate % | -0.40 |
| 5-y EBITDA Growth Rate % | 6.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -65.13 |
| EV-to-EBITDA | 224.65 |
| PEG | -- |
| Shares Outstanding M | 143.18 |
| Net Margin (%) | -10.23 |
| Operating Margin % | -11.32 |
| Pre-tax Margin (%) | -9.14 |
| Quick Ratio | 5.11 |
| Current Ratio | 5.60 |
| ROA % (ttm) | -4.19 |
| ROE % (ttm) | -5.99 |
| ROIC % (ttm) | -18.94 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.35 |
AUPH Number of Guru Trades
AUPH Volume of Guru Trades
Gurus Latest Trades with NAS:AUPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AUPH is held by these investors
Total 2
Aurinia Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:AUPH
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers